JP5199671B2 - 神経センサを有する心臓調律管理デバイス - Google Patents
神経センサを有する心臓調律管理デバイス Download PDFInfo
- Publication number
- JP5199671B2 JP5199671B2 JP2007543138A JP2007543138A JP5199671B2 JP 5199671 B2 JP5199671 B2 JP 5199671B2 JP 2007543138 A JP2007543138 A JP 2007543138A JP 2007543138 A JP2007543138 A JP 2007543138A JP 5199671 B2 JP5199671 B2 JP 5199671B2
- Authority
- JP
- Japan
- Prior art keywords
- nerve
- nerve traffic
- crm
- traffic
- neural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001537 neural effect Effects 0.000 title claims abstract description 91
- 230000000747 cardiac effect Effects 0.000 title claims description 46
- 230000033764 rhythmic process Effects 0.000 title claims description 15
- 210000005036 nerve Anatomy 0.000 claims abstract description 199
- 230000006870 function Effects 0.000 claims abstract description 98
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000008569 process Effects 0.000 claims abstract description 11
- 210000005003 heart tissue Anatomy 0.000 claims abstract description 5
- 108091008698 baroreceptors Proteins 0.000 claims description 61
- 210000001774 pressoreceptor Anatomy 0.000 claims description 61
- 230000000638 stimulation Effects 0.000 claims description 60
- 210000002216 heart Anatomy 0.000 claims description 42
- 230000036772 blood pressure Effects 0.000 claims description 23
- 238000011282 treatment Methods 0.000 claims description 21
- 230000004044 response Effects 0.000 claims description 16
- 108091008690 chemoreceptors Proteins 0.000 claims description 14
- 230000009467 reduction Effects 0.000 claims description 8
- 230000001052 transient effect Effects 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 230000007383 nerve stimulation Effects 0.000 claims description 2
- 230000002107 myocardial effect Effects 0.000 claims 1
- 230000035484 reaction time Effects 0.000 claims 1
- 230000035581 baroreflex Effects 0.000 description 30
- 210000001147 pulmonary artery Anatomy 0.000 description 26
- 210000000577 adipose tissue Anatomy 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- 210000001326 carotid sinus Anatomy 0.000 description 17
- 230000002889 sympathetic effect Effects 0.000 description 15
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 13
- 206010040744 Sinus headache Diseases 0.000 description 11
- 210000003403 autonomic nervous system Anatomy 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 11
- 238000004891 communication Methods 0.000 description 11
- 230000008035 nerve activity Effects 0.000 description 11
- 210000001186 vagus nerve Anatomy 0.000 description 11
- 230000006978 adaptation Effects 0.000 description 10
- 238000007726 management method Methods 0.000 description 10
- 210000002820 sympathetic nervous system Anatomy 0.000 description 10
- 210000002376 aorta thoracic Anatomy 0.000 description 9
- 230000004872 arterial blood pressure Effects 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 9
- 230000004936 stimulating effect Effects 0.000 description 9
- 210000000709 aorta Anatomy 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 210000001640 nerve ending Anatomy 0.000 description 8
- 230000011514 reflex Effects 0.000 description 8
- 210000005241 right ventricle Anatomy 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 210000003192 autonomic ganglia Anatomy 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- 210000002620 vena cava superior Anatomy 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 5
- 210000001011 carotid body Anatomy 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000010349 pulsation Effects 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 210000005242 cardiac chamber Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 description 4
- 210000003492 pulmonary vein Anatomy 0.000 description 4
- 230000035485 pulse pressure Effects 0.000 description 4
- 210000001044 sensory neuron Anatomy 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 210000001631 vena cava inferior Anatomy 0.000 description 4
- 208000003098 Ganglion Cysts Diseases 0.000 description 3
- 208000005400 Synovial Cyst Diseases 0.000 description 3
- 210000002413 aortic body Anatomy 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000007433 nerve pathway Effects 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 230000008904 neural response Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000036513 peripheral conductance Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 210000003102 pulmonary valve Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 230000001457 vasomotor Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000001168 carotid artery common Anatomy 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 210000003748 coronary sinus Anatomy 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000001932 glossopharyngeal nerve Anatomy 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 230000003843 mucus production Effects 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 230000007230 neural mechanism Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 210000000591 tricuspid valve Anatomy 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 208000004557 Vasovagal Syncope Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001008 atrial appendage Anatomy 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000002049 efferent pathway Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 230000001144 postural effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000009153 reflex inhibition Effects 0.000 description 1
- 230000009158 reflex pathway Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 230000009943 skeletal muscle blood flow Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000283 vasomotion Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000004760 visceral afferent Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36557—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by chemical substances in blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36564—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by blood pressure
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Electrotherapy Devices (AREA)
- Electrophonic Musical Instruments (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/992,320 | 2004-11-18 | ||
| US10/992,319 | 2004-11-18 | ||
| US10/992,320 US7769450B2 (en) | 2004-11-18 | 2004-11-18 | Cardiac rhythm management device with neural sensor |
| US10/992,319 US8396560B2 (en) | 2004-11-18 | 2004-11-18 | System and method for closed-loop neural stimulation |
| PCT/US2005/040988 WO2006055436A1 (en) | 2004-11-18 | 2005-11-14 | Cardiac rhythm management device with neural sensor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008520353A JP2008520353A (ja) | 2008-06-19 |
| JP2008520353A5 JP2008520353A5 (enExample) | 2009-01-08 |
| JP5199671B2 true JP5199671B2 (ja) | 2013-05-15 |
Family
ID=35985246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543138A Expired - Fee Related JP5199671B2 (ja) | 2004-11-18 | 2005-11-14 | 神経センサを有する心臓調律管理デバイス |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1812108B1 (enExample) |
| JP (1) | JP5199671B2 (enExample) |
| AT (1) | ATE468154T1 (enExample) |
| DE (1) | DE602005021389D1 (enExample) |
| WO (1) | WO2006055436A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7460906B2 (en) | 2003-12-24 | 2008-12-02 | Cardiac Pacemakers, Inc. | Baroreflex stimulation to treat acute myocardial infarction |
| US8396560B2 (en) | 2004-11-18 | 2013-03-12 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
| US7769450B2 (en) | 2004-11-18 | 2010-08-03 | Cardiac Pacemakers, Inc. | Cardiac rhythm management device with neural sensor |
| US7509166B2 (en) | 2003-12-24 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic baroreflex modulation responsive to adverse event |
| US8200331B2 (en) | 2004-11-04 | 2012-06-12 | Cardiac Pacemakers, Inc. | System and method for filtering neural stimulation |
| US8332047B2 (en) | 2004-11-18 | 2012-12-11 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
| US8473049B2 (en) | 2005-05-25 | 2013-06-25 | Cardiac Pacemakers, Inc. | Implantable neural stimulator with mode switching |
| US8406876B2 (en) | 2005-04-05 | 2013-03-26 | Cardiac Pacemakers, Inc. | Closed loop neural stimulation synchronized to cardiac cycles |
| US7493161B2 (en) | 2005-05-10 | 2009-02-17 | Cardiac Pacemakers, Inc. | System and method to deliver therapy in presence of another therapy |
| US9555252B2 (en) | 2005-04-25 | 2017-01-31 | Cardiac Pacemakers, Inc. | Systems for providing neural markers for sensed autonomic nervous system activity |
| US7640057B2 (en) | 2005-04-25 | 2009-12-29 | Cardiac Pacemakers, Inc. | Methods of providing neural markers for sensed autonomic nervous system activity |
| US7570999B2 (en) | 2005-12-20 | 2009-08-04 | Cardiac Pacemakers, Inc. | Implantable device for treating epilepsy and cardiac rhythm disorders |
| US20070299476A1 (en) * | 2006-06-23 | 2007-12-27 | Euljoon Park | Sympathetic afferent activation for adjusting autonomic tone |
| US8050765B2 (en) | 2006-08-30 | 2011-11-01 | Cardiac Pacemakers, Inc. | Method and apparatus for controlling neural stimulation during disordered breathing |
| US8121692B2 (en) | 2006-08-30 | 2012-02-21 | Cardiac Pacemakers, Inc. | Method and apparatus for neural stimulation with respiratory feedback |
| EP2408518A1 (en) * | 2009-03-09 | 2012-01-25 | Cardiac Pacemakers, Inc. | Systems for autonomic nerve modulation comprising electrodes implantable in a lymphatic vessel |
| JP5600751B2 (ja) | 2009-12-08 | 2014-10-01 | カーディアック ペースメイカーズ， インコーポレイテッド | 埋め込み型医療装置における併用療法検出 |
| WO2011159545A2 (en) | 2010-06-18 | 2011-12-22 | Cardiac Pacemakers, Inc. | Neurostimulation system with control using evoked responses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES226859Y (es) * | 1977-03-03 | 1977-11-16 | Marcapasos cardiaco de ritmo controlado por senales de regu-lacion detectadas en las vias yno los receptores nerviosos. | |
| US5111815A (en) * | 1990-10-15 | 1992-05-12 | Cardiac Pacemakers, Inc. | Method and apparatus for cardioverter/pacer utilizing neurosensing |
| EP0532144B1 (de) * | 1991-09-12 | 1999-02-24 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Herztherapiesystem |
| US6178351B1 (en) * | 1996-08-19 | 2001-01-23 | The Mower Family Chf Treatment Irrevocable Trust | Atrial sensing and multiple site stimulation as intervention means for atrial fibrillation |
| US6738667B2 (en) * | 2000-12-28 | 2004-05-18 | Medtronic, Inc. | Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation |
| JP2004016333A (ja) * | 2002-06-13 | 2004-01-22 | Unique Medical Co Ltd | 硬膜外麻酔用カテーテルおよび該硬膜外麻酔用カテーテルを用いる電気刺激装置 |
| US7835791B2 (en) * | 2002-08-05 | 2010-11-16 | Fujikin Incorporated | Medical treatment system using biological regulation function alternate, cardiac pacing system based on the medical treatment system, blood pressure regulating system, and cardiac disease treating system |
| AU2003286842A1 (en) * | 2002-11-01 | 2004-06-07 | George Mason Intellectual Properties, Inc. | Methods and devices for determining brain state |
-
2005
- 2005-11-14 AT AT05825864T patent/ATE468154T1/de not_active IP Right Cessation
- 2005-11-14 WO PCT/US2005/040988 patent/WO2006055436A1/en not_active Ceased
- 2005-11-14 EP EP05825864A patent/EP1812108B1/en not_active Expired - Lifetime
- 2005-11-14 DE DE602005021389T patent/DE602005021389D1/de not_active Expired - Lifetime
- 2005-11-14 EP EP10150476.9A patent/EP2213331A3/en not_active Withdrawn
- 2005-11-14 JP JP2007543138A patent/JP5199671B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008520353A (ja) | 2008-06-19 |
| EP1812108A1 (en) | 2007-08-01 |
| WO2006055436A1 (en) | 2006-05-26 |
| EP2213331A3 (en) | 2014-08-06 |
| EP1812108B1 (en) | 2010-05-19 |
| ATE468154T1 (de) | 2010-06-15 |
| EP2213331A2 (en) | 2010-08-04 |
| DE602005021389D1 (de) | 2010-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7769450B2 (en) | Cardiac rhythm management device with neural sensor | |
| US10029099B2 (en) | System and method for closed-loop neural stimulation | |
| JP5199867B2 (ja) | 神経マーカを提供するシステム | |
| US7561923B2 (en) | Method and apparatus for controlling autonomic balance using neural stimulation | |
| EP1814627B1 (en) | System for closed-loop neural stimulation | |
| US8332047B2 (en) | System and method for closed-loop neural stimulation | |
| JP5329089B2 (ja) | 持続される圧反射刺激のためのシステム | |
| US7551958B2 (en) | Safety control system for implantable neural stimulator | |
| US8126559B2 (en) | Neural stimulation with avoidance of inappropriate stimulation | |
| JP5199671B2 (ja) | 神経センサを有する心臓調律管理デバイス | |
| JP2008512180A (ja) | モニタされた心臓血管パラメータに基づいた圧反射調節 | |
| US9555252B2 (en) | Systems for providing neural markers for sensed autonomic nervous system activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081112 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081112 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20090309 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090309 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090723 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090723 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110620 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110620 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110915 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110926 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111220 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120618 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120914 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120924 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130121 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130208 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160215 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |